-
Innovation Ranking
NewInnovation Ranking – H. Lundbeck AS
H. Lundbeck AS (Lundbeck), a subsidiary of The Lundbeck Foundation, carries out the research, development, manufacturing, and marketing of pharmaceuticals for the treatment of central nervous system (CNS) diseases including psychiatric and neurological disorders. The company's products are indicated for the treatment of Alzheimer's disease, migraine, depression, Parkinson's disease, schizophrenia, alcohol dependence, anxiety, bipolar I disorder, depression, anxiety, psychosis, and epilepsy, among others. It operates production facilities in Denmark, Italy, and France, and research centers in the US and Denmark....
-
Innovation Ranking
NewInnovation Ranking – H&R Block Inc
H&R Block Inc (H&R Block) is a provider of consumer tax services worldwide. It offers tax return preparation services through professional tax preparers in company-owned and franchise retail tax offices; and provide H&R Block tax software products for the Do-It-Yourself (DIY) consumer. It Offers DIY products through channels such as in-person, online and mobile applications, and desktop software. It also offers services such as refund transfers, emerald advance line of credit, emerald prepaid MasterCard, extended service plan, tax identity shield,...
-
Innovation Ranking
NewInnovation Ranking – H & M Hennes & Mauritz AB
H & M Hennes & Mauritz AB (H&M) is a retailer of fashion apparel and accessories. The company’s products portfolio includes shorts, cardigans, sweaters, blazers suits, t-shirts, sweatshirts, shirts, sports and swimwear, lingerie. It also offers cosmetics and accessories such as jewelry, hats and gloves, belts and suspenders, home textiles, homeware, sunglasses, and watches. The company offers these products under H&M, Afound, COS, Monki, Weekday, Sellpy, Arket and & Other Stories brand names. H & M also sells its products...
-
Innovation Ranking
NewInnovation Ranking – Washington H Soul Pattinson and Co Ltd
Washington H Soul Pattinson and Co Ltd (WHSP) is a diversified investment company. WHSP holds interests in coal mining, copper mining and refining, property investments and consulting. It also invests in pharmaceutical and building products manufacturing companies. WHSP through its subsidiaries, explores, develops, mines and processes coal, oil, gas, copper and gold. It also invests in properties and financial instruments such as hybrid instruments, equities, derivatives and loans. The company serves its products and services to various sectors such as...
-
Product Insights
Complement Factor H – Drugs In Development, 2023
Global Markets Direct’s Complement Factor H provides in depth analysis on Complement Factor H targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Complement Factor H targeted therapeutics...
-
Product Insights
Prostaglandin G/H Synthase 2 – Drugs In Development, 2023
Global Markets Direct’s Prostaglandin G/H Synthase 2 provides in depth analysis on Prostaglandin G/H Synthase 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Prostaglandin G/H Synthase...
-
Product Insights
Prostaglandin G/H Synthase 1 – Drugs In Development, 2023
Global Markets Direct’s Prostaglandin G/H Synthase 1 provides in depth analysis on Prostaglandin G/H Synthase 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Prostaglandin G/H Synthase...
-
Product Insights
Hereditary Inclusion Body Myopathy (h-IBM) – Drugs In Development, 2023
Global Markets Direct’s, ‘Hereditary Inclusion Body Myopathy (h-IBM) - Drugs In Development, 2023’, provides an overview of the Hereditary Inclusion Body Myopathy (h-IBM) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hereditary Inclusion Body Myopathy (h-IBM), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – H-3B6527 in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - H-3B6527 in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. H-3B6527 in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: H-3B6527 is...
-
Product Insights
Ochsner Health – Robert J. and Debra H. Patrick Neuroscience Center – Louisiana
The Ochsner Health – Robert J. and Debra H. Patrick Neuroscience Center – Louisiana project involves the construction of a 12,263m2 neuroscience center in New Orleans, Louisiana, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Ochsner Health – Robert J. and Debra H. Patrick Neuroscience Center – Louisiana report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...